Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cetuximab MeSH Descriptor Data 2026


MeSH Heading
Cetuximab
Tree Number(s)
D12.776.124.486.485.114.224.060.750
D12.776.124.790.651.114.224.060.750
D12.776.377.715.548.114.224.200.750
Unique ID
D000068818
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068818
Scope Note
A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.
Entry Term(s)
C225
Erbitux
IMC C225
IMC-C225
MAb C225
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
PQX0D8J21J
0
Related Numbers
205923-56-4
See Also
ErbB Receptors
Public MeSH Note
2016; CETUXIMAB was indexed under ANTIBODIES, MONOCLONAL 2000-2013; and under ANTIBODIES, MONOCLONAL, HUMANIZED 2013-2015
History Note
2016 (2000)
Date Introduced
2016/01/01
Last Updated
2018/07/02
Cetuximab Preferred
IMC C225 Narrower
Erbitux Narrower
page delivered in 0.17s